![Yao Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yao Lee
Direktor/Vorstandsmitglied bei
INSMED INCORPORATED
Vermögen: 6 Mio $ am 30.06.2026
Profil
Yao Lee is currently an Independent Director at Insmed, Inc. since 2018, President & Representative Director at Novartis Pharma KK since 2020, and President at Merck Serono Co., Ltd. Former roles include President, Director & Senior Director at BIOVIA, Inc. from 1997 to 2003, Non-Executive Director at Regeneus Ltd. from 2020 to 2024, Vice President-Sales at Merck & Co., Inc. from 2008 to 2011, President-Japan at Merck KGaA from 2015 to 2017, GM, Vice President-APAC Sales & Marketing at IQVIA, Inc. from 2003 to 2008, and President-Japan at Allergan UC from 2011 to 2015.
Education includes undergraduate studies at the University of California, Los Angeles.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INSMED INCORPORATED 0,03 % | 13.05.2026 | 57 971 ( 0,03 % ) | 6 Mio $ | 30.06.2026 |
Aktive Positionen von Yao Lee
| Unternehmen | Position | Beginn |
|---|---|---|
| INSMED INCORPORATED | Direktor/Vorstandsmitglied | 17.05.2018 |
Merck Serono Co., Ltd. | Präsident | - |
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Develops, imports, produces and markets pharmaceutical products | Präsident | 01.11.2020 |
Ehemalige bekannte Positionen von Yao Lee
| Unternehmen | Position | Ende |
|---|---|---|
| REGENEUS LTD | Vorstandsvorsitzender | 02.11.2020 |
| MERCK KGAA | Corporate Officer/Principal | 01.01.2017 |
| ALLERGAN PLC | Corporate Officer/Principal | 01.01.2015 |
| MERCK & CO., INC. | Vertrieb & Marketing | 01.01.2011 |
| IMS HEALTH, INC. | Corporate Officer/Principal | 01.01.2008 |
Ausbildung von Yao Lee
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
BIOVIA, Inc.
 BIOVIA, Inc. Packaged SoftwareTechnology Services Develops cloud-based and enterprise R&D, modeling and informatics platform | Technology Services |
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
IQVIA, Inc.
 IQVIA, Inc. Packaged SoftwareTechnology Services Provides AI assistant, analytics and clinical research services for healthcare sector | Technology Services |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Novartis Pharma KK
Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Develops, imports, produces and markets pharmaceutical products | Health Technology |
Merck Serono Co., Ltd. | |
Regeneus Ltd.
 Regeneus Ltd. Pharmaceuticals: MajorHealth Technology Develops innovative cell-based therapies to unmet medical needs in human and veterinary health | Health Technology |
